Unraveling the molecular pathways of DNA-methylation inhibitors

human endogenous retroviruses induce the innate immune response in tumors

Reiner Strick, Pamela L. Strissel, Stephen B Baylin, Katherine B. Chiappinelli

Research output: Contribution to journalArticle

Abstract

Loss of DNA methylation can activate endogenous retroviral expression and dsRNA in cancer cells. This leads to induction of toll-like receptor signaling stimulating an antiviral interferon response. Recent findings provide a therapeutic rationale for combining DNA methylation inhibitors with blockage of immune checkpoint proteins to fight cancer.

Original languageEnglish (US)
JournalOncoImmunology
DOIs
StateAccepted/In press - Apr 25 2016

Fingerprint

Endogenous Retroviruses
DNA Methylation
Innate Immunity
Toll-Like Receptors
Interferons
Antiviral Agents
Neoplasms
Proteins
Therapeutics

Keywords

  • dsRNA
  • IFN-signalling
  • immune checkpoints
  • DNA methylation
  • endogeneous retrovirus (ERV)
  • epigenetic therapy
  • innate immunity
  • TLR

ASJC Scopus subject areas

  • Immunology and Allergy
  • Oncology
  • Immunology

Cite this

Unraveling the molecular pathways of DNA-methylation inhibitors : human endogenous retroviruses induce the innate immune response in tumors. / Strick, Reiner; Strissel, Pamela L.; Baylin, Stephen B; Chiappinelli, Katherine B.

In: OncoImmunology, 25.04.2016.

Research output: Contribution to journalArticle

@article{29986b85a09e498b9d9b7b839859373e,
title = "Unraveling the molecular pathways of DNA-methylation inhibitors: human endogenous retroviruses induce the innate immune response in tumors",
abstract = "Loss of DNA methylation can activate endogenous retroviral expression and dsRNA in cancer cells. This leads to induction of toll-like receptor signaling stimulating an antiviral interferon response. Recent findings provide a therapeutic rationale for combining DNA methylation inhibitors with blockage of immune checkpoint proteins to fight cancer.",
keywords = "dsRNA, IFN-signalling, immune checkpoints, DNA methylation, endogeneous retrovirus (ERV), epigenetic therapy, innate immunity, TLR",
author = "Reiner Strick and Strissel, {Pamela L.} and Baylin, {Stephen B} and Chiappinelli, {Katherine B.}",
year = "2016",
month = "4",
day = "25",
doi = "10.1080/2162402X.2015.1122160",
language = "English (US)",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Landes Bioscience",

}

TY - JOUR

T1 - Unraveling the molecular pathways of DNA-methylation inhibitors

T2 - human endogenous retroviruses induce the innate immune response in tumors

AU - Strick, Reiner

AU - Strissel, Pamela L.

AU - Baylin, Stephen B

AU - Chiappinelli, Katherine B.

PY - 2016/4/25

Y1 - 2016/4/25

N2 - Loss of DNA methylation can activate endogenous retroviral expression and dsRNA in cancer cells. This leads to induction of toll-like receptor signaling stimulating an antiviral interferon response. Recent findings provide a therapeutic rationale for combining DNA methylation inhibitors with blockage of immune checkpoint proteins to fight cancer.

AB - Loss of DNA methylation can activate endogenous retroviral expression and dsRNA in cancer cells. This leads to induction of toll-like receptor signaling stimulating an antiviral interferon response. Recent findings provide a therapeutic rationale for combining DNA methylation inhibitors with blockage of immune checkpoint proteins to fight cancer.

KW - dsRNA

KW - IFN-signalling

KW - immune checkpoints

KW - DNA methylation

KW - endogeneous retrovirus (ERV)

KW - epigenetic therapy

KW - innate immunity

KW - TLR

UR - http://www.scopus.com/inward/record.url?scp=84964653327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964653327&partnerID=8YFLogxK

U2 - 10.1080/2162402X.2015.1122160

DO - 10.1080/2162402X.2015.1122160

M3 - Article

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

ER -